Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

See preview >>

  Email address:
   

For better result, minimum character length is four(4)
Results 131 - 140 of 200 for wx. (0.06 seconds)

WuXi PharmaTech, one of China’s most visible...
Chongqing Zhifei Biological Products bid $93 million for...
It's earnings season, and almost every day for the past...
Bristol-Myers Squibb expects China to become its second...
WuXi PharmaTech, the NY-listed CRO, reported Q2 revenues...
ShangPharma, a CRO that listed on the NYSE in late 2010,...
The US plans to raise $299 million in fees to fund...
WuXi PharmaTech plans to begin offering clinical trial...
Shanghai Pharma is seeking to acquire a mid-sized US or...
prev | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | 15 | 16 | 17 | 18 | 19 | 20 | next
Upcoming Events

ChinaBio® Partnering Forum
September 10–11, 2024 | Shanghai, China
Register here

BIO-Europe®
November 4–6, 2024 | Stockholm, Sweden
Save €900 before September 13!
Register here

Biotech Showcase™
January 13–15, 2025 | San Francisco, CA
Save $600 before September 27!
Other Relevant Events

Antibody Engineering & Therapeutics Asia
October 21–23, 2024 | Kyoto, Japan
Save 30% with code CHINABIO30!
Register here